Podium to Practice: EHA 2025 – Multiple Myeloma: ELEVATED CTC NUMBERS ASSOCIATE WITH A HIGHLY PR AND GENOMICALLY COMPLEX PHENOTYPE IN NDMM PATIENTS

Podium to Practice: EHA 2025 – Multiple Myeloma: ELEVATED CTC NUMBERS ASSOCIATE WITH A HIGHLY PR AND GENOMICALLY COMPLEX PHENOTYPE IN NDMM PATIENTS

Podium to Practice: EHA 2025
Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Donna Reece

Icon Chair Speaker

Speakers

Dr. Irwin Sandhu

Dr. Maria Victoria Mateos Manteca

Studies / Trials Discussed

S196 – ELEVATED CIRCULATING TUMOR CELL (CTC) NUMBERS ASSOCIATE WITH A HIGHLY PROLIFERATIVE (PR) AND GENOMICALLY COMPLEX PHENOTYPE IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS

Studies/trials discussed:

S196 – ELEVATED CIRCULATING TUMOR CELL (CTC) NUMBERS ASSOCIATE WITH A HIGHLY PROLIFERATIVE (PR) AND GENOMICALLY COMPLEX PHENOTYPE IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS
Tagged